CTLA-4-Ig (also known as abatacept) is a human fusion protein that consists of the extracellular domain of CTLA-4 and the Fc portion of IgG1, which is used for the treatments of RA patients. The gene discussed is CTLA4; the disease is rheumatoid arthritis.